Crinetics Pharmaceuticals
CRNX
CRNX
80 hedge funds and large institutions have $465M invested in Crinetics Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
6% less funds holding
Funds holding: 85 → 80 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Holders
80
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$8.4M | |
| 2 | +$4.34M | |
| 3 | +$2.87M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$985K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$855K |
Top Sellers
| 1 | -$7.96M | |
| 2 | -$2.43M | |
| 3 | -$1.86M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$661K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$490K |